end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccruedIncomeTaxesCurrent,AccruedLiabilitiesAndOtherLiabilities,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsFairValueDisclosure,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ConversionOfStockAmountConverted1,ConvertiblePreferredStockSharesIssuedUponConversion,CurrentFederalTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredRevenueCurrent,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DefinedContributionPlanCostRecognized,DepreciationAndAmortization,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,GeneralAndAdministrativeExpense,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestAndOtherIncome,LeaseCost,LesseeOperatingLeaseDiscountRate,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NumberOfOperatingSegments,NumberOfReportableSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OtherAssetsNoncurrent,OtherLiabilitiesNoncurrent,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCash,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityLiquidationPreference,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,TemporaryEquityValueExcludingAdditionalPaidInCapital,UnbilledReceivablesCurrent,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WeightedAverageNumberDilutedSharesOutstandingAdjustment,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,EffectiveIncomeTaxRateReconciliationTaxCreditsForeign,IncreaseDecreaseInContractWithCustomerAsset,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
2020-09-30,2020-12-10,10-Q,"ATEA PHARMACEUTICALS, INC.",AVIR,CIK0001593899,USD,4476000.0,,,6340000.0,126000.0,9295000.0,,4238000.0,4238000.0,,110106000.0,108413000.0,105383000.0,96609000.0,105490000.0,,56475053.0,0.001,80529575.0,10109847.0,10109847.0,10000.0,0.0,,48958829.0,,0.0,,,,,,,,,,,,5000.0,-1.74,-1.74,-1.74,,,,,,,,822000.0,14923000.0,4028000.0,0.0,-17622000.0,,,,,,,,7000.0,,,,,,,10872000.0,110106000.0,10816000.0,,,,-17622000.0,,,17629000.0,-17629000.0,,70000.0,,,,,625000.0,,200000.0,340000.0,85000.0,1644000.0,56000.0,,,,,,,3030000.0,,,,,,175000.0,49000.0,13601000.0,107000.0,-85816000.0,,,,,,,,,2857918.0,1.47,,,,3115000.0,,22406000.0,7001747.0,3.65,22406000.0,7001747.0,3.65,,,15371000.0,-76511000.0,,,,,175745000.0,178106000.0,0.001,57932090.0,48958829.0,48958829.0,175745000.0,,,,,,,10109847.0,10109847.0,10109847.0,,,,,,,
2020-12-31,2021-03-30,10-K,"ATEA PHARMACEUTICALS, INC.",AVIR,CIK0001593899,USD,60000.0,,,14368000.0,132000.0,612879000.0,657000.0,6800000.0,7457000.0,,863632000.0,863477000.0,850117000.0,846701000.0,850224000.0,828456000.0,16163783.0,0.001,300000000.0,82436937.0,82436937.0,82000.0,0.0,283230000.0,,,0.0,,0.0,301367000.0,16985000.0,0.0,14069000.0,53000.0,1791000.0,1072000.0,16985000.0,,19000.0,-0.51,-0.51,-0.51,0.0,0.21,-0.173,-0.136,,-0.026,-0.125,2743000.0,33240000.0,21640000.0,0.0,-10947000.0,,-488000.0,5815000.0,12437000.0,301367000.0,,7296000.0,83000.0,,,,,,,315831000.0,863632000.0,315795000.0,531748000.0,-26000.0,296734000.0,-10947000.0,1.0,1.0,59663000.0,-11030000.0,,303000.0,,,,,540000.0,340000.0,,200000.0,,107000.0,36000.0,,26000.0,0.001,10000000.0,0.0,0.0,7545000.0,317605000.0,27000.0,214116000.0,,-10947000.0,180000.0,48000.0,38023000.0,107000.0,-65160000.0,48633000.0,7457000.0,0.0,,0.917,0.8,0.0056,0.0031,3246548.0,1.88,588964.0,6.83,4613861.0,,14.93,277894000.0,7917783.0,6.68,277894000.0,7917783.0,6.68,1.43,14.93,129531000.0,547801000.0,18747.0,283230000.0,317605000.0,27000.0,,,0.001,0.0,0.0,0.0,,5815000.0,0.0,0.0,1888000.0,,,21592441.0,21592441.0,21592441.0,,5815000.0,,,,,
2021-03-31,2021-05-13,10-Q,"ATEA PHARMACEUTICALS, INC.",AVIR,CIK0001593899,USD,3792000.0,,,15104000.0,,620622000.0,,7273000.0,7273000.0,1532944.0,840649000.0,840145000.0,833751000.0,805994000.0,833858000.0,-16366000.0,,0.001,300000000.0,82736937.0,82736937.0,83000.0,,,,0.0,,0.0,,235382000.0,,,,,,,,,7000.0,0.37,,0.34,,,,,,,,824000.0,,8759000.0,,,,3732000.0,,6628000.0,-65985000.0,356000.0,-1151000.0,58000.0,76000.0,0.07,456000.0,200000.0,256000.0,19000.0,254391000.0,840649000.0,254278000.0,471000.0,,-16837000.0,30713000.0,,,35330000.0,30655000.0,70000.0,,437000.0,323000.0,114000.0,356000.0,,,,,,463000.0,113000.0,,,0.001,10000000.0,0.0,0.0,6394000.0,,,,471000.0,30713000.0,,41000.0,26571000.0,107000.0,-34447000.0,65985000.0,7273000.0,,,,,,,,,,,,2212250.0,,,,,,,,,,,586258000.0,,,,471000.0,,,,,,,,,,,,6000.0,6521239.0,89099075.0,,82577836.0,,,,,,,
2021-06-30,2021-08-12,10-Q,"ATEA PHARMACEUTICALS, INC.",AVIR,CIK0001593899,USD,10701000.0,50000000.0,7200000.0,37961000.0,,630686000.0,,10007000.0,10007000.0,3548713.0,871543000.0,871110000.0,816460000.0,811693000.0,816567000.0,,,0.001,300000000.0,82776937.0,82776937.0,83000.0,,,,,7200000.0,,,224991000.0,,,,,,,,76000.0,,0.02,,0.02,,,,,,,,1765000.0,,11901000.0,,8739000.0,7200000.0,,,,,,,52000.0,82000.0,0.07,371000.0,200000.0,171000.0,10000.0,273682000.0,871543000.0,273653000.0,,,,1539000.0,,,51704000.0,8687000.0,71000.0,,361000.0,332000.0,29000.0,293000.0,,,,,,400000.0,29000.0,,,0.001,10000000.0,0.0,0.0,4650000.0,,,,,,,33000.0,39803000.0,107000.0,-32908000.0,60391000.0,,,,,,,,,,,,,1022045.0,,,,,,,,,,,597861000.0,,,,57000.0,,,,,,,,,,,,11000.0,5347854.0,88091384.0,,82743530.0,,,,,,,
2021-09-30,2021-11-12,10-Q,"ATEA PHARMACEUTICALS, INC.",AVIR,CIK0001593899,USD,22190000.0,,12002000.0,47682000.0,,642471000.0,,10990000.0,10990000.0,5119092.0,843504000.0,842946000.0,839660000.0,811731000.0,839965000.0,,,0.001,300000000.0,83047079.0,83047079.0,83000.0,,,,,6100000.0,,,192180000.0,,,,,,,,102000.0,,-0.34,,-0.34,,,,,,,,2903000.0,,11939000.0,,-22094000.0,6100000.0,,,,,,,53000.0,75000.0,0.07,286000.0,200000.0,86000.0,7000.0,262052000.0,843504000.0,262052000.0,,,,-28194000.0,,,54958000.0,-22147000.0,71000.0,,279000.0,279000.0,,227000.0,,,,,,532000.0,,,,0.001,10000000.0,0.0,0.0,3286000.0,,,,,,,26000.0,43019000.0,305000.0,-61102000.0,32811000.0,,,,,,,,,,,,,206000.0,,,,,,,,,,,581452000.0,,,,795000.0,,,,,,,,,,,,4000.0,,82815636.0,,82815636.0,,,,,,,
2021-12-31,2022-02-28,10-K,"ATEA PHARMACEUTICALS, INC.",AVIR,CIK0001593899,USD,4534000.0,,2572000.0,52349000.0,161000.0,653964000.0,,39621000.0,39621000.0,,772892000.0,772403000.0,764375000.0,731767000.0,764680000.0,-85544000.0,19667801.0,0.001,300000000.0,83102730.0,83102730.0,83000.0,0.0,,,,17400.0,,,,10904000.0,0.0,,256000.0,,5643000.0,10904000.0,272000.0,29000.0,1.46,,1.37,0.125,0.21,-0.044,,-0.014,0.032,0.041,4209000.0,128036000.0,45785000.0,0.0,138590000.0,17400000.0,10289000.0,,43877000.0,-301367000.0,161000.0,483000.0,213000.0,318000.0,0.07,4308000.0,989000.0,,,62815000.0,772892000.0,56883000.0,1465000.0,-4000.0,-87005000.0,121190000.0,1.0,1.0,212990000.0,138377000.0,281000.0,318000.0,,197000.0,,161000.0,,,,,,466000.0,5932000.0,,4000.0,0.001,10000000.0,0.0,0.0,8028000.0,,1465000.0,,,121190000.0,184000.0,23000.0,167205000.0,305000.0,56030000.0,351367000.0,39621000.0,0.0,0.85,,,,,4561016.0,11.33,296313.0,24.64,3561295.0,,39.1,31239000.0,10516972.0,22.87,31239000.0,10516972.0,22.87,2.2,55.14,23500000.0,710077000.0,665793.0,,,1465000.0,,,,,,,,,,,-6081000.0,37000.0,5429206.0,88249243.0,,82820037.0,0.061,,855000.0,838000.0,821000.0,805000.0,0.008
